Efficacy of the new lutamides in metastatic hormone-sensitive prostate cancer (mHSPC)
This Medudy course is a video tutorial for physicians on the topic of “The Efficacy of New Lutamides in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).” Prof. Dr. Peter Hammerer, Chief Physician at the Department of Urology at Braunschweig Municipal Hospital, presents an overview of the efficacy and clinical classification of the new androgen receptor inhibitors (“lutamides”) in metastatic hormone-sensitive prostate cancer (mHSPC). Topics covered include […]